medigraphic.com
Colegio de Medicina Interna de México.

2021, Number 6

<< Back Next >>

Med Int Mex 2021; 37 (6)

Eosinophilic esophagitis

Camargo-Abril N, Santiago-Barrios J, Varela L, Maestre-Serrano R, Rodríguez-María R

Language: Spanish
References: 17
Page: 1094-1098
PDF size: 202.54 Kb.


ABSTRACT

Background: Eosinophilic esophagitis is a chronic inflammatory disease characterized by infiltration of eosinophils at the level of the esophageal epithelium and is one of the conditions to be evaluated in adults with dysphagia and food impaction. In recent years, there has been an increase in case reports predominantly in western medical literature. In Colombia there are few cases reported with this condition, so there is no clear the prevalence about this disease.
Clinical case: A 48-year-old male patient with heartburn, dysphagia and episodes of alimentary impaction, diagnosed by antecedents, symptoms, endoscopic findings and histological confirmation. Treatment with proton pump inhibitors and dietary restrictions was started for four weeks with a follow-up of 6 months, with which the patient responded satisfactorily with permanent relief of symptoms and without complications related to the treatment.
Conclusions: In Colombia the exact prevalence of eosinophilic esophagitis is not known; however, it is considered an emerging disease. Therefore, it should be included in the differential diagnosis of dysphagia in adults, which allows establishing the timely diagnosis and treatment, the relief of symptoms and, consequently, the improvement of the patient’s quality of life.


REFERENCES

  1. Liacouras CA, Furuta GT, Hirano I, Atkins D, Attwood SE, Bonis PA, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011; 128 (1): 3-20. doi: 10.1016/j.jaci.2011.02.040.

  2. Ahmad M, Soetikno RM, Ahmed A. The differential diagnosis of eosinophilic esophagitis. J Clin Gastroenterol 2000; 30 (3): 242-4.

  3. Mackenzie SH, Go M, Chadwick B, Thomas K, Fang J, Kuwada S, et al. Eosinophilic esophagitis in patients presenting with dysphagia–a prospective analysis. Aliment Pharmacol Ther 2008; 28 (9): 1140-6. doi: 10.1111/j.1365- 2036.2008.03795.x.

  4. Kelley ML Jr, Frazer JP. Symptomatic mid-esophageal webs. JAMA 1966; 197 (2): 143-6. doi:10.1001/jama.1966. 03110020131047.

  5. García-Compeán D, González-González JA, González-Moreno EI, Maldonado-Garza HJ. La esofagitis eosinofílica. ¿El Norte contra el Sur? Enfoque mecanicista bio-económicosocial e implicaciones clínicas. Rev Gastroenterol Méx 2017; 82 (4): 328-36. DOI: 10.1016/j.rgmx.2017.02.007.

  6. Hurrell JM, Genta RM, Dellon ES. La prevalencia de eosinofilia esofágica varía según la zona climática en los Estados Unidos. Am J Gastroenterol 2012; 107: 698.

  7. Forero P, López P, Sierra A. Esofagitis eosinofílica en adultos, una entidad clínico-patológica emergente. Gastroenterol latinoam 2013; 24 (3): 121-31.

  8. Rodríguez R, Bohórquez M.A, González I, Torregroza G. Desórdenes eosinofílicos gastrointestinales (DEGI): presentación de dos casos. Rev Col Gastroenterol 2007; 22 (2): 138-48.

  9. Shoda T, Wen T, Aceves SS, Abonia JP, Atkins D, Bonis PA, et al. Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR). Eosinophilic esophagitis endotype classification by molecular, clinical, and histopathological analyses: a cross-sectional study. Lancet Gastroenterol Hepatol 2018;3:477-88.

  10. Kidambi T, Toto E, Ho N, Taft T, Hirano I. Temporal trends in the relative prevalence of dysphagia etiologies from 1999- 2009. World J Gastroenterol 2012;18:4335-41.

  11. Baños-Madrid R, Rodrigo-Agudo JL, Ballester-Rosique C, Chacón-Martínez S, Alberca-de las Parras F, Molina- Martínez J, et al. Disfagia de larga evolución en paciente con esofagitis eosinofílica. Rev Col Gastroenterol 2019; 21 (4): 275-77.

  12. Kanakala V, Lamb CA, Haigh C, Stirling RW, Attwood SE. The diagnosis of primary eosinophilic oesophagitis in adults: missed or misinterpreted?. Eur J Gastroenterol Hepatol 2010; 22 (7): 848-55. doi: 10.1097/ MEG.0b013e32832c7709.

  13. Dellon ES, Liacouras CA, Molina-Infante J, Furuta GT, Spergel JM, Zevit N, et al. Updated international consensus diagnostic criteria for eosinophilic esophagitis: Proceedings of the AGREE conference. Gastroenterology 2018; 155 (4): 1022-33. doi: 10.1053/j.gastro.2018.07.009.

  14. Jurado-Zambrano LF, Arroyave-Benavides J, Jiménez- Uribe AM, Vera-Chamorro JF, Zambrano-Pérez CA, López-Panqueva R. Caracterización clínico-patológica de la esofagitis eosinofílica en niños y adolescentes en el Hospital Universitario Fundación Santa Fe de Bogotá. Rev Colomb Gastroenterol 2019; 34 (1): 23-30. https://doi. org/10.22516/25007440.264.

  15. Muñoz-Ortiz E, Juliao-Baños F. Esofagitis eosinofílica: estado actual. IATREIA 2013; 26 (1): 54-66.

  16. Straumann A, Conus S, Degen L, Frei C, Bussmann C, Beglinger C, et al. Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2011; 9 (5): 400-9. doi: 10.1016/j.cgh.2011.01.017.

  17. Jung KW, Gundersen N, Kopacova J, Arora AS, Romero Y, Katzka D, et al. Occurrence of and risk factors for complications after endoscopic dilation in eosinophilic esophagitis. Gastrointest Endosc 2011; 73 (1): 15-21. doi: 10.1016/j. gie.2010.09.036.




2020     |     www.medigraphic.com